Hemab Therapeutics Holdings, Inc. (COAG)

Summary

Current Price
As of today, COAG price is $51.74, up +3.75% on
Current Price All-Time High
COAG price is currently -3.49% below its historical high of $53.61 set on
Market Cap
COAG current market cap is $2B
Revenue
COAG current annual revenue is $0.00, unchanged year-over-year
Next Earnings
The next earnings release for COAG is on

Profile

Company profile for Hemab Therapeutics Holdings, Inc. (COAG)
MetricValue
Full NameHemab Therapeutics Holdings, Inc.
TickerNASDAQ: COAG
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
IndexesNot included
Websitehemab.com
Employees59

Key Metrics

Hemab Therapeutics Holdings, Inc. Key Details
MetricValueDate
Price$51.74
Price, 1D Change+3.75%
$2B
-
-
1.24
$0.00
Revenue, 1Y Change0.00%
-$31.82
EPS, 1Y Change-31.22%

Chart

SUGGESTED SERIES
Hemab Therapeutics Holdings, Inc. chart

Events

Hemab Therapeutics Holdings, Inc. Events
MetricValueDate
Next Earnings
Last Qtr. EarningsN/A
Last Ann. EarningsN/A
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

COAG Estimates
MetricValueDate
-$31.82
EPS Estimate-$3.06N/A
EPS Est. Change+90.37%N/A
$0.00
Revenue Estimate-N/A
Revenue Est. Change-N/A
Current Price$51.74
Price Target$50.00-
Price Tgt. Change-3.36%-

🔒 Log In To Unlock Full Data

EPS

COAG EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
--$24.25-
--$31.82-
-$3.06N/A+90.37%
-$2.51N/A+92.10%
COAG EPS reported versus estimate values chart

Revenue

COAG revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
-$0.00-
-$0.00-
-N/A-
-N/A-
COAG revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

COAG Performance
MetricValueDate
Price, 1Y-
Price, 3Y-
-
-
0.00%
0.00%
-31.22%
-31.22%

🔒 Log In To Unlock Full Data

Technicals

COAG Technical Indicators
MetricValueDate
Current Price$51.74
$34.40
$37.35
-
$39.59
$3.58
1.24
$4.02
63.63
76.34%

Dividends

COAG Dividends
MetricValueDate
-N/A
UpcomingN/AN/A
-
-
$0.00
0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

COAG Income & Profitability
MetricValueDate
$0.00
-$31.82
-$304.00K
-
-$70.12M
-
-$63.91M
-
-$69.82M

🔒 Log In To Unlock Full Data

Financial Health

COAG Financial Health
MetricValueDate
-2.05
18.03
18.03
-
-
2.53

Valuations

COAG Valuations
MetricValueDate
-
-
-12.17
-111.06
-N/A

Balance Sheet

COAG Balance Sheet
MetricValueDate
-$176.64M
$185.49M
$194.78M
$192.55M
$371.42M
$10.68M
$361.43M
$693.00K
$5.73M

Expenses

COAG Expenses
MetricValueDate
$63.91M
$69.82M
$304.00K
$10.49M
$304.00K
$0.00
-$227.00K

Cash Flow

COAG Cash Flow
MetricValueDate
-$61.48M
-$81.48M
$156.30M
$16.00K
-$61.49M

Recent analyst updates

COAG Recent analyst updates
MetricValueDate
Wedbush
Jefferies
HC Wainwright & Co.
HC Wainwright & Co.
HC Wainwright & Co.
Wedbush
Jefferies
Goldman Sachs
Evercore ISI Group

Analyst sentiment

Sentiment over the past month
COAG analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
COAG institutional ownership distribution chart

Screeners with COAG

FAQ

What is the ticker symbol for Hemab Therapeutics Holdings, Inc.?
The ticker symbol for Hemab Therapeutics Holdings, Inc. is NASDAQ:COAG
Does Hemab Therapeutics Holdings, Inc. pay dividends?
No, Hemab Therapeutics Holdings, Inc. does not pay dividends
What sector is Hemab Therapeutics Holdings, Inc. in?
Hemab Therapeutics Holdings, Inc. is in the Healthcare sector
What industry is Hemab Therapeutics Holdings, Inc. in?
Hemab Therapeutics Holdings, Inc. is in the Biotechnology industry
What country is Hemab Therapeutics Holdings, Inc. based in?
Hemab Therapeutics Holdings, Inc. is headquartered in United States
When did Hemab Therapeutics Holdings, Inc. go public?
Hemab Therapeutics Holdings, Inc. initial public offering (IPO) was on May 1, 2026
Is Hemab Therapeutics Holdings, Inc. in the S&P 500?
No, Hemab Therapeutics Holdings, Inc. is not included in the S&P 500 index
Is Hemab Therapeutics Holdings, Inc. in the NASDAQ 100?
No, Hemab Therapeutics Holdings, Inc. is not included in the NASDAQ 100 index
Is Hemab Therapeutics Holdings, Inc. in the Dow Jones?
No, Hemab Therapeutics Holdings, Inc. is not included in the Dow Jones index
When does Hemab Therapeutics Holdings, Inc. report earnings?
The next expected earnings date for Hemab Therapeutics Holdings, Inc. is August 14, 2026

Data Sources & References

  1. COAG Official Website www.hemab.com
  2. COAG Profile on Yahoo Finance finance.yahoo.com/quote/COAG
  3. COAG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/coag